VICI Properties Reaffirms Guidance

The following is a summary of the Company's full-year 2024 guidance:For the Year Ending December 31, 2024 ($ in millions): Low HighEstimated Adjusted Funds From Operations

The following is a summary of the Company’s full-year 2024 guidance:

For the Year Ending December 31, 2024 ($ in millions):   Low   High
Estimated Adjusted Funds From Operations (AFFO)   $2,320   $2,355
Estimated Adjusted Funds From Operations (AFFO) per diluted share   $2.22   $2.25
Estimated Weighted Average Share Count for the Year (in millions)   1,046.0   1,046.0

 

Total
0
Shares
Related Posts
Read More

Biora Therapeutics Submits Updated IND Application For BT-600; Update Includes Supplemental Information And Provides Additional Time To Complete Regulatory Review; Biora Anticipates Remaining On Track With Its Phase 1 Clinical Trial Execution Timeline

Update includes supplemental information and provides additional time to complete regulatory review Biora anticipates remaining on track with its phase 1 clinical trial execution timeline Biora Therapeutics,

BIOR